Permeability of bacteria to antibacterial agents

Antibiotic Discovery and Development

Volumn 9781461414001, Issue , 2012, Pages 849-879

  Nichols, Wright W ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949177747     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1400-1_26     Document Type: Chapter

References (135)

1. Akama H, Matsuura T, Kashiwagi S et al (2004) Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J Biol Chem 279:25939-25942
2. Amidon GE, Xiaorong H, Hageman MJ (2003) Physicochemical characterization and principles of oral dosage form selection. In: Abraham DJ (ed) Burger's medicinal chemistry and drug discovery, vol 2, 6th edn, Drug development. Wiley, Hoboken, pp 649-682
3. Bean RC, Shepherd WC, Chan H (1968) Permeability of lipid bilayer membranes to organic solutes. J Gen Physiol 52:495-508
4. Bellido F, Martin NL, Siehnel RJ, Hancock REW (1992) Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability. J Bacteriol 174:5196-5203
5. Block MH, Nichols WW (2001) Design of antibacterial agents. In: Sussman M (ed) Molecular medical microbiology. Academic, San Diego, pp 609-626
6. Chakrabarti AC, Deamer DW (1992) Permeability of lipid bilayers to amino acids and phosphate. Biochim Biophys Acta 1111:171-177
7. Chowhan ZUD, Yotsuyanagi T, Higuchi WL (1972) Model transport studies utilizing lecithin spherules. I. Critical evaluations of several physical models in the determination of the permeability coefficient of glucose. Biochim Biophys Acta 266:320-342
8. Collander R (1954) The permeability of Nitella cells to non-electrolytes. Physiol Plant 7:420-445
9. Costerton JW, Cheng KJ, Geesey GG et al (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41:435-464
10. Crank J (1975) The mathematics of diffusion, 2nd edn. Oxford University Press, Oxford
11. Cronan JE, Gennis RB, Maloy SR (1987) Cytoplasmic membrane. In: Neidhardt FC (ed) Escherichia coli and Salmonella typhimurium: cellular and molecular biology. ASM Press, Washington, DC, pp 31-55
12. Cui L, Iwamoto A, Lian JQ et al (2006) Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50: 428-438
13. Davis DR, McAlpine JB, Pazoles CJ et al (2001) Enterococcus faecalis multi-drug resistance transporters: application for antibiotic discovery. J Mol Microbiol Biotechnol 3:179-184
14. Deamer DW, Bramhall J (1986) Permeability of lipid bilayers to water and ionic solutes. Chem Phys Lipids 40:167-188
15. Decad GM, Nikaido H (1976) Outer membrane of gram-negative bacteria XII. Molecular sieving function of cell wall. J Bacteriol 128:325-336
16. Demchick P, Koch AL (1996) The permeability of the wall fabric of Escherichia coli and Bacillus subtilis. J Bacteriol 178:768-773
17. Duy D, Soll J, Philippar K (2007) Solute channels of the outer membrane: from bacteria to chloroplasts. Biol Chem 388:879-889
18. Eicher T, Brandstätter L, Pos KM (2009) Structural and functional aspects of the multidrug efflux pump AcrB. Biol Chem 390:693-699
19. Epand RM, Epand RF (2009) Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788:289-294
20. Gale EF (1971) 'Don't talk to me about permeability' the tenth Marjory Stephenson memorial lecture. J Gen Microbiol 68:1-14
21. Gale EF, Cundliff E, Reynolds PE et al (1981) The molecular basis of antibiotic action. Wiley, London, pp 554-556
22. Goldman RC, Capobianco JO (1990) Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance ot 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother 34:1973-1980
23. Goldman RC, Scaglione F (2004) The macrolide-bacterium interaction and its biological basis. Curr Drug Targets Infect Disord 4:241-260
24. Goldman R, Kohlbrenner W, Lartey P, Pernet A (1987) Antibacterial agents specifically inhibiting lipopolysaccharide synthesis. Nature 329:162-164
25. Gualtieri M, Banéres-Roquet F, Villain-Guillot P et al (2009) The antibiotics in the chemical space. Curr Med Chem 16:390-393
26. Hammarlund-Udenaes M, Bredberg U, Fridén M (2009) Methodologies to assess brain drug delivery in lead optimization. Curr Top Med Chem 9:148-162
27. Hammond SM, Claesson A, Jansson AM et al (1987) A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis. Nature 327:730-732
28. Hancock REW (1984) Alterations in outer membrane permeability. Annu Rev Microbiol 38:237-264
29. Hancock REW (1997) The bacterial outer membrane as a drug barrier. Trends Microbiol 5:37-42
30. Hancock REW, Brinkman FSL (2002) Function of pseudomonas porins in uptake and efflux. Annu Rev Microbiol 56:17-38
31. Harder KJ, Nikaido H, Matsuhashi M (1981) Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob Agents Chemother 20: 549-552
32. Hassan KA, Skurray RA, Brown MH (2007) Active export proteins mediating drug resistance in staphylococci. J Mol Microbiol Biotechnol 12:180-196
33. Hauser H, Oldani D, Phillips MC (1973) Mechanism of ion escape from phosphatidylcholine and phosphatidylserine single bilayer vesicles. Biochemistry 12:4507-4517
34. Hecker M, Antelmann H, Büttner K, Bernhardt J (2008) Gel-based proteomics of gram-positive bacteria: a powerful tool to address physiological questions. Proteomics 8:4958-4975
35. Hewinson RG, Cartwright SJ, Slack MPE et al (1989) Permeability to cefsulodin of the outer membrane of Pseudomonas aeruginosa and discrimination between b -lactamase-mediated trapping and hydrolysis as mechanisms of resistance. Eur J Biochem 179:667-675
36. Higgins MK, Bokma E, Koronakis E et al (2004) Structure of the periplasmic component of a bacterial drug efflux pump. Proc Natl Acad Sci USA 101:994-999
37. Hill AV (1928) The diffusion of oxygen and lactic acid through tissues. Proc R Soc Lond B 104:39-96
38. Hooper DC (2002) Fluoroquinolone resistance among gram-positive cocci. Lancet Infect Dis 2:530-538
39. Howden BP, Davies JK, et al (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Micr Rev 23:99-139
40. Hsieh PC, Siegel SA et al (1998) Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc Natl Acad Sci USA 95:6602-6606
41. Jellen-Ritter AS, Kern WV (2001) Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Esherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother 45:1467-1472
42. Kadner RJ (1996) Cytoplasmic membrane. In: Neidhardt FC (ed) Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, DC, pp 58-87
43. Källman O, Giske CG et al (2009) Interpay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli. Microb Drug Resist 15:91-95
44. Koch AL (1990) Diffusion. The crucial process in many aspects of the biology of bacteria. Adv Microb Ecol 11:37-70
45. Koebnik R, Locher KP, van Gelder P (2000) Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol 37:239-253
46. Koronakis V, Sharff A, Koronakis E et al (2000) Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914-919
47. Köster W (2004) Transport of solutes across biological membranes: prokaryotes. In: van Leeuwen HP, Köster W (eds) Physicochemical kinetics and transport at biointerfaces. Wiley, Hoboken, Volume 9, pp 271-335
48. Kuhn B, Mohr P, Stahl M (2010) Intramolecular hydrogen bonding in medicinal chemistry. J Med Chem 53:2601-2611
49. Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57:1486-1513
50. Lakaye B, Dubus A, Lepage S et al (1999) When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with b -lactams. Mol Microbiol 31:89-101
51. Lambert PA (2002) Cellular impermeability and uptake of biocides and antibiotics in Grampositive bacteria and mycobacteria. J Appl Microbiol Symp Suppl 92:46S-54S
52. Lawrence L, Danese P, DeVito J et al (2008) In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens. Antimicrob Agents Chemother 52:1653-1662
53. Lee A, Mao W, Warren MS et al (2000) Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 182:3142-3150
54. Lewis K (2001) In search of natural substrates and inhibitors of MDR pumps. J Mol Microbiol Biotechnol 3:247-254
55. Li XZ, Nikaido H (2004) Efflux-mediated drug resistance in bacteria. Drugs 64:159-204
56. Li XZ, Nikaido H (2009) Efflux-mediated drug resistance in bacteria. An update. Drugs 69:1555-1623
57. Li XZ, Livermore DM, Nikaido H (1994) Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 38:1732-1741
58. Li XZ, Ma D, Livermore DM, Nikaido H (1994) Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob Agents Chemother 38:1742-1752
59. Lieb WR, Stein WD (1986) Simple diffusion across the membrane bilayer. In: Stein WD (ed) Transport and diffusion across cell membranes. Academic, Orlando, pp 69-112
60. Lim SP, Nikaido H (2010) Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob Agents Chemother 54:1800-1806
61. Lomovskaya O, Watkins WJ (2001) Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem 8:1699-1711
62. Macielag MJ (2012) Chemical properties of antimicrobials and their uniqueness
63. Markham PN, Neyfakh AA (2001) Efflux-mediated drug resistance in gram-positive bacteria. Curr Opin Microbiol 4:509-514
64. Masuda N, Sakagawa E et al (2000) Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3322-3327
65. Matias VRF, Beveridge TJ (2006) Native cell wall organization shown by cryo-electron microscopy confirms the existence of a periplasmic space in Staphylococcus aureus. J Bacteriol 188:1011-1021
66. Mazzariol A, Cornaglia G, Nikaido H (2000) Contributions of the AmpC b -lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to b -lactams. Antimicrob Agents Chemother 44:1387-1390
67. Midgley M (1986) The phosphonium ion efflux system of Escherichia coli: relationship to the ethidium efflux system and energetic studies. J Gen Microbiol 132:3187-3193
68. Moore SD, Sauer RT (2008) Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22. Proc Natl Acad Sci USA 105:18261-18266
69. Morris DM, Jensen GJ (2008) Toward a biomechanical understanding of whole bacterial cells. Annu Rev Biochem 77:583-613
70. Murakami S, Nakashima R, Yamashita E, Yamaguchi A (2002) Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587-593
71. Murakami S, Nakashima R, Yamashita E et al (2006) Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443:173-179
72. Nikaido H, Nagano K (2009) Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci USA 106:5854-5858
73. Nakae T (1986) Outer-membrane permeability of bacteria. Crit Rev Microbiol 13:1-62
74. Nichols WW (1987) Towards a fundamental understanding of the MIC of b -lactam antibiotics. J Antimicrob Chemother 22:275-283
75. Nichols WW (1989) Susceptibility of biofilms to toxic compounds. In: Characklis WG, Wilderer PA (eds) Structure and function of biofilms, S Bernhard, Dahlem Konferenzen. Wiley, New York, pp 321-331
76. Nichols WW (1991) Biofims, antibiotics and penetration. Rev Med Microbiol 2:177-181
77. Nichols WW (1994) Biofilm permeability to antibacterial agents. In: Wimpenny J, Nichols W, Stickler D, Lappin-Scott H (eds) Bacterial biofilms and their control in medicine and industry. BioLine, Cardiff, pp 141-149
78. Nichols WW (2012) A quantitative kinetic modeling approach to analyzing the permeation of antibacterial agents into bacteria, including the interplay between net inward passive diffusion and pump-mediated efflux
79. Nichols WW, Dorrington SM, Slack MPE, Walmsley HL (1988) Inhibition of tobramycin diffusion by binding to alginate. Antimicrob Agents Chemother 32:518-523
80. Nichols WW, Evans MJ, Slack MPE, Walmsley HL (1989) The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol 135:1291-1303
81. Nikaido H (1976) Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta 433:118-132
82. Nikaido H (1996) Outer membrane. In: Neidhardt FC (ed) Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, DC, pp 29-47
83. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593-656
84. Nikaido H (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78:119-146
85. Nikaido H, Hancock REW (1986) Outer membrane permeability of Pseudomonas aeruginosa. In: Sokatch JR (ed) The bacteria, vol 10. Academic, New York/London, pp 145-193
86. Nikaido H, Normark S (1987) Sensitivity of Escherichia coli to various b -lactam antibiotics is determined by the interplay of outer-membrane permeability and degradation by periplasmic b -lactamases: a quantitative predictive treatment. Mol Microbiol 1:29-36
87. Nikaido H, Rosenberg EY (1981) Effect of solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli. J Gen Physiol 77:121-135
88. Nikaido H, Rosenberg EY (1983) Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J Bacteriol 153:241-252
89. Nikaido H, Thanassi DG (1993) Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob Agents Chemother 37:1393-1399
90. Nikaido H, Vaara M (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1-31
91. Nikaido H, Rosenberg EY, Foulds J (1983) Porin channels in Escherichia coli: studies with b -lactams in intact cells. J Bacteriol 153:232-240
92. Nikaido H, Basina M, Nguyen V, Rosenberg EY (1998) Multidrug efflux pump AcrAB of Salmonella typhumurium excretes only those b -lactam antibiotics containing lipophilic side chains. J Bacteriol 180:4686-4692
93. Norbeck DW, Rosenbrook W, Kramer JB et al (1989) A novel prodrug of an impermeant inhibitor of 3-deoxy-D- manno -2-octulosonate cytidylyltransferase has antibacterial activity. J Med Chem 32:625-629
94. O'Shea R, Moser HE (2008) Physocochemical properties of antibacterial compounds: implications for drug discovery. J Med Chem 51(10):2871-2878
95. Pagès JM, James CE, Winterhalter M (2008) The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 6:893-903
96. Plésiat P, Nikaido H (1992) Outer membranes of gram-negative bacteria are permeable to steroid probes. Mol Microbiol 6:1323-1333
97. Plésiat P, Aires JR, Godard C, Köhler T (1997) Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa. J Bacteriol 179:7004-7010
98. Poole K (2001) Multidrug resistance in gram-negative bacteria. Curr Opin Microbiol 4:500-508
99. Poole K (2004) Efflux-mediated multiresistance in gram-negative bacteria. Clin Microbiol Infect 10:12-26
100. Poole K (2012) Efflux-mediated antimicrobial resistance
101. Pos KM, Schiefner A, Seeger MA, Diederichs K (2004) Crystallographic analysis of AcrB. FEBS Lett 564:333-339
102. Quale J, Bratu S, Gupta J, Landman D (2006) Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50:1633-1641
103. Quinn JP, Dudek EJ, DiVincenzo CA et al (1986) Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis 154:289-294
104. Renkin EM (1954) Filtration, diffusion, and molecular sieving through porous cellulose membranes. J Gen Physiol 38:225-243
105. Roberts IS (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol 50:285-315
106. Roughton FJW (1959) Diffusion and simultaneous chemical reaction velocity in haemoglobin solutions and red cell suspensions. Prog Biophys Biophys Chem 9:55-104
107. Sanchez L, Wubin P et al (1997) The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J Bacteriol 179:6855-6857
108. Schoberth SM, Bär NK, Krämer R, Kärger J (2000) Pulsed high-field gradient in vivo NMR spectroscopy to measure diffusional water permeability in Corynebacterium glutamicum. Anal Biochem 279:100-105
109. Schulz GE (1993) Bacterial porins: structure and function. Curr Opin Cell Biol 5:701-707
110. Schulz GE (2002) The structure of bacterial outer membrane proteins. Biochim Biophys Acta 1565:308-317
111. Severina II, Muntyan MS, Lewis K, Skulachev VP (2001) Transfer of cationic antibacterial agents berberine, palmatine, and benzalkonium through bimolecular planar phospholipid film and Staphylococcus aureus membrane. Life 52:321-324
112. Shivaji S, Prakash JS (2010) How do bacteria sense and respond to low temperatures? Arch Microbiol 192:85-95
113. Sigler A, Schubert P, Hillen W, Niederweis M (2000) Permeation of tetracyclines through membranes of liposomes and Escherichia coli. Eur J Biochem 277:527-534
114. Silver LL (2008) Are natural products still the best source for antibacterial drug discovery? The bacterial entry factor. Expert Opin Drug Discov 3:487-500
115. Slack MPE, Nichols WW (1982) Antibiotic penetration through bacterial capsules and exopolysaccharides. J Antimicrob Chemother 10:368-372
116. Smit J, Kamio Y, Nikaido H (1975) Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants. J Bacteriol 124:942-958
117. Snyder DS, McIntosh TJ (2000) The lipopolysaccharide barrier: Correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe kinetics, Biochemistry 39, 11777-11787.
118. Stein WD (1986) Transport and diffusion across cell membranes. Academic, Orlando
119. Stein WD (1986) Thermodynamics and kinetics of the diffusion process. In: Stein WD (ed) Transport and diffusion across cell membranes. Academic, Orlando, pp 35-46
120. Stein WD (1997) Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev 77:545-590
121. Stewart PS (2003) Diffusion in biofilms. J Bacteriol 185:1485-1491
122. Sulavik MC, Houseweart C, Cramer C et al (2001) Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 45:1126-1136
123. Taber H (2008) Antibiotic permeability. In: Wax RG (ed) Bacterial resistance to antimicrobials, 2nd edn. CRC Press, Boca Raton, pp 169-182
124. Taylor JB, Kennewell PD (1993) Modern medicinal chemistry. Ellis Horwood, Chichester
125. Trias J, Nikaido H (1990) Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 34:52-57
126. Vaara M (1992) Agents that increase the permeability of the outer membrane. Microbiol Rev 56:395-411
127. Vachon V, Lyew DJ, Coulton JW (1985) Transmembrane permeability channels across the outer membrane of Haemophilus influenzae type b. J Bacteriol 162:918-924
128. Waley SG (1987) An explicit model for bacterial resistance: application to b -lactam antibiotics. Microbiol Sci 4:143-146
129. Walter A, Gutknecht J (1986) Permeability of small nonelectrolytes through lipid bilayer membranes. J Membr Biol 90:207-217
130. Wang YF, Dutzler R, Rizkallah PJ et al (1997) Channel specificity: structural basis for sugar discrimination and differential flux rates in maltoporin. J Mol Biol 272:56-63
131. Webber MA, Piddock LJV (2003) The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51:9-11
132. Weiner JH, Li L (2008) Proteome of the Escherichia coli envelope and technological challenges in membrane proteome analysis. Biochim Biophys Acta 1778:1698-1713
133. Weingart H, Petrescu M, Winterhalter M (2008) Biophysical characterization of in- and efflux in gram-negative bacteria. Curr Drug Targets 9:789-796
134. Xiang TX, Anderson BD (1994) The relationship between permeant size and permeability in lipid bilayer membranes. J Membr Biol 140:111-122
135. Yoshimura F, Nikaido H (1985) Diffusion of b -lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 27:84-92